SynthesisJournal of orthopaedic surgery and research2026
Comparative efficacy of platelet-rich plasma monotherapy versus combination therapies for knee osteoarthritis: a systematic review and network meta-analysis.
Synthesis in Journal of orthopaedic surgery and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hydrogel-Based Therapies for Female Stress Urinary Incontinence: From Bulking Agents to Regenerative Platforms-A Narrative Review.Current urology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPlatelet-rich plasma (PRP) is widely used as an intra-articular treatment for knee osteoarthritis (KOA), but whether combining PRP with hyaluronic acid (HA), mesenchymal stem cells (MSCs), or ozone (O
methodsTwelve electronic databases were searched from inception to April 2026 for randomized controlled trials (RCTs) that compared intra-articular PRP alone with PRP combined with HA, MSCs, or O
resultsEighteen RCTs involving 1,376 participants met the inclusion criteria. The evidence network was star-shaped, with PRP alone serving as the sole common comparator. For WOMAC function, PRP + HA was the only combination that demonstrated a statistically significant improvement over PRP alone (MD = - 6.16, 95% CI - 9.71 to - 2.61, P < 0.001). Differences were not significant for PRP + O
conclusionsAmong PRP-based combination therapies for KOA, the addition of HA to PRP is supported by the most consistent evidence for improving pain and function. Current data are insufficient to conclude that adding MSCs or O
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.